Trial intelligence / Profile preview

Magnesium sulfate for reducing oxygen desaturation during one-lung ventilation in thoracotomy

IRCT20250923067343N4Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of magnesium sulfate in hypoxia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of hypoxia. Started Jun 2026; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

hypoxia

Beyond the preview

Go deeper on IRCT20250923067343N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250923067343N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call